StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Reported Revenue Growth — Analytical Instruments by Quarter

Reported Revenue Growth — Analytical Instruments (%)

QuarterlyAnnual

Thermo Fisher Scientific Reported Revenue Growth — Analytical Instruments: 6.0% in Q3 2026, up 1.0 pts from a year earlier.

Latest, Q3 2026
6.0%
Period ended Sep 30, 2026
Change on a year earlier
+1.0 pts
5.0% in Q3 2025
History
16 quarters
Since Q3 2022
Sources
4
Documents cited below

Where the Q3 2026 figure comes from

“AI: Total revenue growth 2% -3% 5% 1% 1% 0% 7% 6%”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package & SEC MD&A.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedReported Revenue Growth — Analytical Instruments (%)Year on yearSource
Q3 2026Sep 30, 20266.0%+1.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20267.0%+10.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20260.0%-2.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20251.0%-6.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20255.0%+2.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 2025-3.0%-5.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20252.0%+4.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20247.0%-1.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20243.0%-5.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20242.0%-7.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 2024-2.0%-16.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20238.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20238.0%-2.0 ptsQ4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20239.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 202314.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2022Sep 30, 202210.0%–SEC Form 10-Q (10q_2022Q3, filed 2022-11-04) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Reported Revenue Growth — Analytical Instruments (%), quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org-reported-pct-ai

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.